You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hepatitis, Chronic

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis b Trial (RBD1016, RBD1016+PegIFN-a)

Not yet recruiting
  • Chronic Hepatitis b
  • (no location specified)
Jul 25, 2023

Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C Trial in Bucuresti (Bemnifosbuvir, Ruzasvir)

Recruiting
  • Chronic Hepatitis C Virus
  • +4 more
  • Bucuresti, BUC, Romania
    Atea Study Site
Jun 15, 2023

Hepatitis B, Chronic Trial in Auckland (VIR-3434, VIR-2218, TDF)

Recruiting
  • Hepatitis B, Chronic
  • Auckland, New Zealand
  • +1 more
Dec 19, 2022

Chronic Hepatitis B and Hepatitis D Co-infection Trial in Changchun (HH-003 20mg/kg, HH-003 3mg/kg)

Active, not recruiting
  • Chronic Hepatitis B and Hepatitis D Co-infection
  • HH-003 20mg/kg
  • HH-003 3mg/kg
  • Changchun, Jilin, China
    First Hospital of Jilin University
Dec 30, 2022

Chronic Hepatitis b Trial in Beijing, Chongqing (STSG-0002 Injection)

Not yet recruiting
  • Chronic Hepatitis b
  • STSG-0002 Injection
  • Beijing, Beijing, China
  • +3 more
Mar 6, 2023

Hepatic Inflammation, Fibrosis and Prognosis in CHB and NAFLD

Recruiting
  • Chronic Hepatitis b
  • Non-alcoholic Fatty Liver Disease
    • Nanjing, China
      Nanjing Drum Tower Hospital
    Mar 2, 2023

    Chronic Hepatitis b, Anti-PD-1 Antibody, Peg-IFNa Trial in Chongqing (Anti-PD-1 antibody, NAs, Peg-IFNa)

    Not yet recruiting
    • Chronic Hepatitis b
    • +2 more
    • Anti-PD-1 antibody
    • +2 more
    • Chongqing, Chongqing, China
      The 2nd affiliated Hospital of Chongqing Medical University
    Mar 14, 2023

    Chronic Hepatitis b, Anti-PD-1 Antibody Trial in Chongqing (Anti-PD-1 antibody, NAs)

    Not yet recruiting
    • Chronic Hepatitis b
    • Anti-PD-1 Antibody
    • Anti-PD-1 antibody
    • NAs
    • Chongqing, Chongqing, China
      The 2nd affiliated Hospital of Chongqing Medical University
    Mar 3, 2023

    Chronic Hepatitis B Trial in Hong Kong, Auckland (VRON-0200-AdC6, VRON-0200-AdC7)

    Recruiting
    • Chronic Hepatitis B
    • VRON-0200-AdC6
    • VRON-0200-AdC7
    • Hong Kong, Hong Kong
    • +1 more
    Oct 6, 2023

    Chronic Hepatitis B Trial (GS-2829, GS-6779, Placebo for GS-2829)

    Not yet recruiting
    • Chronic Hepatitis B
    • GS-2829
    • +3 more
    • (no location specified)
    Mar 14, 2023

    Chronic Hepatitis b Trial in Taiwan (Nuc Discontinuation, Entecavir or Tenofovir)

    Active, not recruiting
    • Chronic Hepatitis b
    • Nuc Discontinuation
    • Entecavir or Tenofovir
    • Chiayi City, Taiwan
    • +5 more
    Mar 30, 2023

    Chronic Hepatitis b Trial in Beijing, Chongqing (STSG-0002 Injection)

    Not yet recruiting
    • Chronic Hepatitis b
    • STSG-0002 Injection
    • Beijing, Beijing, China
    • +3 more
    Mar 6, 2023

    Chronic Hepatitis b Trial in Changchun (GST-HG141)

    Recruiting
    • Chronic Hepatitis b
    • Changchun, Jilin, China
      The first hospital of Jilin University
    Dec 5, 2022

    Chronic Hepatitis B Trial in Hong Kong (Tenofovir alafenamide(TAF), Tenofovir disoproxil fumarate(TDF))

    Recruiting
    • Chronic Hepatitis B
    • Tenofovir alafenamide(TAF)
    • Tenofovir disoproxil fumarate(TDF)
    • Hong Kong, Hong Kong
      Humanity and Health GI and Liver Centre
    Dec 19, 2022

    Chronic Hepatitis B Trial in Monterey Park (NCO-48 Fumarate 4 mg, NCO-48 Fumarate 20 mg, Tenofovir Alafenamide 25 mg)

    Completed
    • Chronic Hepatitis B
    • NCO-48 Fumarate 4 mg
    • +2 more
    • Monterey Park, California
      National Institute of Clinical Research, Inc
    Jan 3, 2023

    Chronic Hepatitis B Trial in Seoul (Standard of care)

    Active, not recruiting
    • Chronic Hepatitis B
    • Standard of care
    • Seoul, Korea, Republic of
    • +3 more
    Mar 29, 2023

    Chronic Hepatitis b Trial in Chongqing, Xi'an (Placebo, TQA3605 tablets, Entecavir dispersible tablets)

    Recruiting
    • Chronic Hepatitis b
    • Placebo
    • +4 more
    • Chongqing, Chongqing, China
    • +2 more
    Nov 27, 2023

    HBeAg-negative CHB Patients With Indeterminate Phase

    Recruiting
    • Chronic Hepatitis b
    • Observation
    • Antiviral treatment
    • Changzhou, Jiangsu, China
    • +4 more
    Dec 21, 2022

    Long Term Follow up of Chronic HCV Patients Receiving DAAS

    Recruiting
    • Chronic Hepatitis c
      • Sohag, Egypt
        Sohag University Hospital
      Jun 29, 2022

      Hepatitis D, Chronic Trial in Auckland (VIR-2218, VIR-3434)

      Not yet recruiting
      • Hepatitis D, Chronic
      • Auckland, New Zealand
        Investigative Site
      Jul 12, 2022

      Cirrhosis Portal Trial (EUS guided portal pressure gradient measurement)

      Not yet recruiting
      • Cirrhosis Portal
      • EUS guided portal pressure gradient measurement
      • (no location specified)
      Oct 24, 2022

      Chronic Hepatitis b, Liver Fibrosis Trial in Konya (Serum regucalcin level)

      Completed
      • Chronic Hepatitis b
      • Liver Fibrosis
      • Serum regucalcin level
      • Konya, Turkey
        Konya Training and Research Hospital
      Jun 23, 2022

      Chronic Hepatitis B Trial in Shatin (Tenofovir alafenamide, Entecavir)

      Not yet recruiting
      • Chronic Hepatitis B
      • Shatin, Hong Kong
        Prince of Wales Hospital
      Jun 15, 2022

      Chronic Hepatitis B Trial in Hannover (Human hepatitis B Immunoglobulin (Hepatect®CP/Zutectra®))

      Recruiting
      • Chronic Hepatitis B
      • Human hepatitis B Immunoglobulin (Hepatect®CP/Zutectra®)
      • Hannover, Lower Saxony, Germany
        Hannover Medical School, Department for Gastroenterology, Hepato
      May 31, 2022

      HBe Negative Chronic Hepatitis B, Hepatitis B Viral Infection Trial in Marseille (CLEVUDINE + TENOFOVIR PLACEBO, CLEVUDINE IN

      Terminated
      • HBe Negative Chronic Hepatitis B
      • Hepatitis B Viral Infection
      • CLEVUDINE + TENOFOVIR PLACEBO
      • +2 more
      • Marseille, France
        Hôpital Saint Joseph
      Jan 30, 2023